June 20, 2018 3:14 PM ET

Pharmaceuticals

Company Overview of Calixa Therapeutics, Inc.

Calixa Therapeutics, Inc. INSIDERS ON Board Members

Name (Connections)RelationshipsTitleAge
There is no Company Insiders data available.

Other Board Members on Board Members

Name (Connections)RelationshipsType of Board MembersPrimary CompanyAge
Eckhard Weber 10 RelationshipsChairman of the BoardCalixa Therapeutics, Inc.--
George Talbot M.D.59 RelationshipsMember of Advisory BoardNabriva Therapeutics plc69
William Craig M.D.25 RelationshipsMember of Advisory BoardAtterx Biotherapeutics, Inc.--
David Nicolau PharmD.21 RelationshipsMember of Advisory BoardTetraphase Pharmaceuticals, Inc.--
Joseph Solomkin M.D.37 RelationshipsMember of Advisory BoardTetraphase Pharmaceuticals, Inc.--
John Edwards Jr., M.D.10 RelationshipsMember of Advisory BoardNovaDigm Therapeutics, Inc.--
David Livermore 56 RelationshipsMember of Advisory BoardTetraphase Pharmaceuticals, Inc.--
Dennis Podlesak 30 RelationshipsMember of the Board of DirectorsDomain Associates, L.L.C.59
Brenton Ahrens 138 RelationshipsMember of the Board of DirectorsCanaan Partners54
Mark Wilcox M.D., FRCPath58 RelationshipsMember of Advisory BoardSynthetic Biologics, Inc.--
Eckard Weber 29 RelationshipsMember of the Board of DirectorsNanothera Corporation67
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Connected People on the Calixa Therapeutics, Inc. Board

NameRelationships
Brenton K. Ahrens 138 Relationships
George Harrison Talbot M.D.59 Relationships
Mark Wilcox M.D., FRCPath58 Relationships
David Livermore 56 Relationships
Joseph S. Solomkin M.D.37 Relationships

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Calixa Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.